BETA

Awaiting Council decision on delegated act



2013/2903(DEA) Exemption for lead acetate markers for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment
RoleCommitteeRapporteurShadows
Lead ENVI
Lead committee dossier: ENVI/7/14362

Activites

  • 2014/01/07 Delegated act not objected by Parliament
  • 2013/10/23 Committee referral announced in Parliament, 1st reading/single reading
  • 2013/10/18 Initial period for examining delegated act 2 month(s)
  • 2013/10/18 Non-legislative basic document
    • C(2013)06794

Documents

  • Non-legislative basic document published: C(2013)06794

History

(these mark the time of scraping, not the official date of the change)

activities/3
date
2013-12-19T00:00:00
body
unknown
type
Delegated act not objected by Council
procedure/stage_reached
Old
Awaiting Council decision on delegated act
New
Procedure completed - delegated act enters into force
activities/3
date
2014-01-07T00:00:00
body
unknown
type
Delegated act not objected by Parliament
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Council decision on delegated act
activities/2
date
2013-10-23T00:00:00
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
procedure/dossier_of_the_committee
ENVI/7/14362
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
activities
  • date: 2013-10-18T00:00:00 body: unknown type: Initial period for examining delegated act 2 month(s)
  • date: 2013-10-18T00:00:00 docs: type: Non-legislative basic document published title: C(2013)06794 type: Non-legislative basic document body: EC commission:
committees
  • body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
links
other
    procedure
    reference
    2013/2903(DEA)
    title
    Exemption for lead acetate markers for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment
    stage_reached
    Preparatory phase in Parliament
    summary
    Supplementing
    subtype
    Examination of delegated act
    type
    DEA - Delegated acts procedure
    subject